Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not me. I was ok sending a letter to VDRM's securities counsel but not to the SEC. To me, it's one of those be careful what you wish for scenarios. We may win the battle but lose the war if the stock becomes untradeable. Honestly though I don't know much about the complaint process as to whether they will jump on it and take it seriously or throw it in a pile with the rest of the penny scam complaints.
Has anyone made out a complaint yet?
What happened to our 3 new employee's we just hired did we lay them off already?
They used to communicate with shareholders. Now they don't and have not in several months. Reading through many of the posts on ihub it seems like no one has been able to get any information from the useless IR guy or Otiko either. Everything was looking good in 2023 and thought we were turning a corner with the company but it seems like many more Otiko lies again.
You were cheerleading this company not too long ago. You misplaced your rose colored glasses apparently. Now you are posting like you just discovered America…..but I’ve been livin here for years
Maybe their business model is that VDRM will not actually carry inventory. I had noted that the Company has not reported any inventory on the balance sheet for about 3 years. Something that GC pointed out ...the fact that they created a distributor (Viaderma Distribution) may be such that the distributor is the entity that is supposed to actually carry the inventory. Or maybe the Company intends to sell direct from the manufacturer in which case the Company never takes title to the inventory. Maybe this all would be relevant with a real company; coming from Otiko, it's likely all fraudulent bullsh*t.
In fairness, Viaderma is at fault with all of this. NOT ONE of their PRs or social media updates have proved to be the least bit valid in the past several years.
Vitastem shipments overseas in March? It's a big ass nothing burger. Same with Nupelo, VA, HMO, Dubai deals, OTC up listing. And now for weeks there are no products available for sale on the website. No inventory? WTF is going on here. Especially with their misleading financial statements with so many discrepancies that they won't even answer about.
Otiko and Rich Inza are behind all of this. They've gone completely silent for months and are hiding from shareholders. It sure seems very fraudulent what they're doing or not doing for the company's shareholders and Otiko needs to be held accountable.
Here is a SEC complaint form https://help.sec.gov/s/investor-complaint
And you would think with 5000 posts on VDRM He would of been right at least once. But that never happened😂
Looks like a VERY sloppy pumper was wrong here the ENTIRE time 😢 😂
They have Zero product to sell. No miracles here. So sorry
Safe to say Otiko is a con man. Still not one response from him or useless rich from IR either in many months now who probably quit working with them for all we know.
Talking with litigation attorneys this week. Enough is enough.
Congrats Otiko. Trading in .004s, a new low. You must be so proud.
Nope, been around quite a while though! This one looks to be toes up, do you disagree? Reading through recent posts and attempts to communicate with doc and IR, seems there isn’t much to be said anyway..
Hey trani3, you don't say much do you?
Received a response from Attorney Grace:
Kenneth C. Grace
From:
kgrace@lashwilcoxandgrace.com
To:
David *****
Cc:
drotiko@yahoo.com
Wed, Jul 10 at 12:02 PM
Thank you for writing. I’ll make an inquiry.
Sent from my iPhone
cotiko@viaderma.com
chris.otiko@viaderma.com
chris@viaderma.com
richardinza@gmail.com
Thanks, I am going to resend it. I don't expect any answers but I'll give it a shot.
What email addresses did you use? Were they any of these below? Only ones found online so far.
drotiko@yahoo.com
chris@viaderma.com
ir@viaderma.com
info@viaderma.com
https://willtrustkengrace.com/contact-me/
KGrace@LashWilcoxandGrace.com
This is powerful and I believe the Doc second this on all of us, me included, suckers 😂
“Listen, Here’s The Thing. If You Can’t Spot The Sucker In Your First Half-Hour At The Table, Then You Are The Sucker.”
With love, From California: The Doc. OTIKO
It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so. “
That is really scary. Not surprised either. The Doc is a piece of work
That info been there for years, I researched such long ago. That info, it is not current with Latest filings dropped by ViaDerma
The attorney email and both Otiko email addresses have bounced back as undeliverable. The attorney's email was rejected and Otikos emails indicated that his addresses no longer exist. This guy is slippery.
I just sent this email to securities counsel, Otiko and Rich:
Dear Mr. Grace, Esq.,
I am a long time shareholder of Viaderma, Inc. ("VDRM"). I noticed that you/your office is listed as securities counsel in connection with the quarterly report of VDRM issued for the period ending March 31, 2024.
Per my review of the public records in Nevada, I noticed that Viaderma, Inc. is listed as revoked although no termination date is listed:
Entity Name: VIADERMA, INC. Entity Number: E0155292010-5
Entity Type: Domestic Corporation (78) Entity Status: Revoked
Formation Date: 04/06/2010 NV Business ID: NV20101250034
Termination Date: Annual Report Due Date: 4/30/2023
I also noticed that shortly before the Annual Report Due Date, an entity was created in California with the same name:
Viaderma, Inc., a Nonprofit Corporation - CA Mutual Benefit on 2/9/23
It appears that the Nevada publicly held entity has ceased to exist while an entity with the same name, albeit a Nonprofit Corporation - CA Mutual Benefit has been created around the same time period; the principals of both entities being Christopher Otiko.
None of this information has been disclosed in the quarterly report, although the transactions occurred and the information was available prior to publication of the report. Furthermore, I believe a reasonable prudent investor would find this information to be relevant and material and one that could affect an investment decision and therefore such information should have been publicly disclosed either via a quarterly report or a separate public disclosure.
I am hopeful that the information provided in this email is not complete and that the Company has and will provide a reasonable explanation for the revocation of the Company in Nevada and the apparent reincorporation in California.
Also we hope that the Company will update the shareholders in the near future on a very long list of public announcements concerning potential business activities over the past 7 years; none of which have ever come to fruition. In this vein, the footnotes to the financial statements have not been updated in five years and fail to comply with the company's legal obligation to disclose current relevant financial information on the business activities of the company.
Thank you.
Anyone have any idea what is going on??
Also found this in California
VIADERMA, INC. (5501054)
Initial Filing Date 02/09/2023
Status Active
Standing - SOS Good
Standing - FTB Good
Standing - Agent Good
Standing - VCFCF Good
Formed In CALIFORNIA
Entity Type Nonprofit Corporation - CA - Mutual Benefit
Principal Address 5901 WEST CENTURY BLVD
SUITE 750
LOS ANGELES, CA 90045
Mailing Address 4 BAHAMA BEND
CORONADO,CA92118
Statement of Info Due Date 02/28/2025
Agent Individual
Christopher Otiko
4 BAHAMA BEND
CORONADO, CA 92118
Found this about Viaderma, Inc. in Nevada:
Entity Name: VIADERMA, INC. Entity Number:E0155292010-5
Entity Type: Domestic Corporation (78)Entity Status: Revoked
Formation Date:04/06/2010NV Business ID:NV20101250034
Termination Date: Annual Report Due Date:4/30/2023
Registered AGENT INFORMATION
Name of Individual or Legal Entity:. Resigned Status: Resigned
CRA Agent Entity Type: Registered Agent Type: Non-Commercial Registered Agent
OFFICER INFORMATION View Historical Data
Title Name Address Last Updated Status
President CHRISTOPHER AYODELE OTIKO 23251 HAMLIN ST, West Hills, CA, 91307, USA 04/29/2021 Active
President CHRIS OTIKO 4640 ADMIRALTY WAY SUITE 500, MARINA DEL REY, CA, 90292, USA 04/29/2018 Active
Secretary CHRIS OTIKO 4640 ADMIRALTY WAY SUITE 500, MARINA DEL REY, CA, 90292, USA 04/29/2018 Active
Treasurer CHRIS OTIKO 4640 ADMIRALTY WAY SUITE 500, MARINA DEL REY, CA, 90292, USA 04/29/2018 Active
Director CHRIS OTIKO 4640 ADMIRALTY WAY SUITE 500, MARINA DEL REY, CA, 90292, USA 04/29/2018 Active
CURRENT SHARES
Class/Series Type Share Number Value
Common 1,250,000,000 0.000100000000
Preferred 50,000,000 0.001
So (trying to put a positive spin on things), it is not necessarily a bad thing that VDRM has no inventory on the balance if the business plan is that Viaderma Distribution, Inc. handles that end of the business? I'd feel a little better about it if VD was a wholly owned subsidiary of VDRM and not privately held by the largest shareholder and insider of VDRM.
Wound Pros(tetracyte) and Brewer Wellness(Bwell) both offer the original formula tetracycline 3%. Seems to me they solved the staining issue with that product and successfully stripped it away from Viaderma…only to be replaced by Bacitracin. Seems legit🤡
I don’t even know if his real name is OTIKO anymore. Nobody knows crap about VDRM. Last thing we have been capable to confirm, by some of us purchasing the product that it works and it is of good quality. Beyond those facts: NADA. That guy with bird logo is the one that has been the closest from obtaining intel from this company straight. However, he has been keeping a low profile lately, wonder why. Maybe nothing to say as well
You are correct. I was just rechecking in advance of posting the same regarding inventory.
Since online sales resumed in December 2022, through 1Q24, a piddling total of $1,636 has been recorded on Consolidated Statement of Operations. With the 3-7 years out of date nature of significant textual information in financial reports, best guess is the minuscule revenue is from the agreement with Viaderma Distribution, Inc (formerly Biogenx, Inc.). The agreement is for Viaderma to receive 50% of gross profit plus 5% gross sales as licensing fee. Thus, the underlying online sales have been nominal to minimal. Out of pocket price point of $99, now $149, without predicted medicare/medicaid/insurance and fsa/hsa otc approval, severely limits prospective customer base. Viaderma Distribution, Inc. would be carrying inventory, if there was any, on their balance sheet.
Looking at past balance sheets, it doesn't appear that the company reported any inventory since June 2021. GC would know better.
What does it matter? We have 1 product to sell and the shelf is empty .. great way to run a business. Where is the $$$ from the sale of what we did have on the shelf …Dr. Needs to get his head out of his ass….
How can we be out of stock?? What's the new shelf life , any one know ??
I really would give all my shares away just to try to understand the way of thinking of the Doc. Otiko, or a least to know the kind of man he is, really. Even criminals and drug dealers understand the concept of supply and demand and the basic of such in order to fulfill their ambitions of becoming super rich.
Somehow Otiko does not know how to accomplish this....
Here's why:
VIADERMA PRODUCT, HAS BEEN CONFIRMED THAT IT WORKS AND IT IS GOOD.... HE DOES NOT NEED TO INVENT THE WHEEL TO SUCCEED IN HERE... HE GOT THE CAPITAL TO START SMALL AND SPREAD ORDERS ALL OVER... HE CAN EVEN ASK FOR LOANS OR PARTNER OR SELL IT ALL FOR 100M IF he believes he cant keep up and go and enjoy life...
This is very embarrassing his position right now, cant wait for current fillings to get audited and the Next Q1 to be dropped
Now, thru history, some smart people or potentials inherit, self destructive tendencies or addictions. Maybe Otiko is like this dude from the BREAKING BAD series... LMAO... He just does not give a fu$%^ck and just want to hang out with mamasitas around and LAMBO and expensive bling bling. Maybe he just want to be involved in Hip pop and be called Santa... His album: Bad-Santa-Rap-Sheet
It absolutely amazes me that the doc would be RICH beyond imagination because of his self appointed millions of shares and bonuses, if he would just concentrate on Vitastem and finish what he started with a proven product. Why settle for Pennie’s when he could be raking in millions ??? SMFH 🤷🏼
Always a great way to start a business >>
replenished ? No time frame. Price don't matter because we don't have any to sell anyway.
Any questions just call IR and listen to the same voice mail.
At least we know why no large orders have been processed. You can't sell it if you don.t have it.
ViaDerma is not taking orders Not even @ $149.95
Is it a secret why they don't have it OR if they ever will??
The time came to put up or shut up Looks like they chose both. Just my thoughts & opinion. GLTA
"Product is out of stock and orders are not being accepted until stock is replenished"...and the dog ate my homework.
If for a moment I believed that the company ever had any inventory to begin with, I might be excited to think that the product was selling like hotcakes and flying off the shelf notwithstanding the jacked-up price of $149. In the real world and not la la land, where the company has no inventory, no sales, and no cash, once again I find the company to be totally full of sh*t to the point where the company appears to making intentional material misreprentations and deliberately misleading shareholders about the status of company assets and revenues and business activities. Company leaders have no shame and will do anything to maintain the illusion of a viable enterprise.
Show me financial statements audited by an independent CPA firm reporting material sales and revenues earned and collected from a third party not affiliated with VDRM and I will be happy to tout company accomplishments. Until then, its all smoke and mirrors IMHO.
So, the product is out of stock on the website. Must be because of all the product that went overseas in March and production just can't keep up. Right. Most of the Doc's focus has been on the new suppository product which he will have and share more news soon. There is going to be a super jumbo size which should make DB and Sloppy ecstatic with anticipation. Sit tight fellas. LMMFAO
Vitastem Ultra 55ML Spray
Product is out of stock and orders are not being accepted until stock is replenished
Regular price
149.95
Tax included.
I have used the older version for years. Burns, wounds, it's the best and that's why I hope it finally be marketed and priced reasonable. The world needs this stuff. :)
“Listen, Here’s The Thing. If You Can’t Spot The Sucker In Your First Half-Hour At The Table, Then You Are The Sucker.”
By: Doctor OTIKO
Fas Let me spell it out for you HYPOCRITE
Followers
|
617
|
Posters
|
|
Posts (Today)
|
4
|
Posts (Total)
|
74426
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.
A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.
The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.
Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.
In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.
We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.
Per 3/8/18 PR: ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
Per 12/7/17 PR: The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments.
Per 1/23/18 PR: The Company has also a licensing and distribution agreement in place with its Canadian partners to produce a CBD Topical Serum, which has a 92% absorption rate powered by ViaDerma's Patent Pending Dual Carrier Technology. The CBD and Terpene profile (enriched with specific essential oils and vitamins C, and D) is crafted to alleviate Chronic Dry Skin, Psoriasis, Eczema, Rosacea, and many other skin conditions. The serum has anti-inflammatory, anti-bacterial, and chronic pain relief properties that are absorbed by the skin and provide overall healing benefits. Sales are expected to begin in the first quarter of 2018 and are projected to generate approximately $2 million annual revenues.
The Patented Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
CBD is a compound found in the Cannabis family of plants such as hemp. CBD is combined into our topical body care products like Elixr's Topical Balm, Serum, and Spray.
CBD is an antioxidant. Antioxidants protect our skin from damaging exposure to smoke, UV rays, and environmental pollutants. Cannabinoid receptors are located all throughout the skin, Topical CBD products interact with those receptors resulting homeostasis and healing. Studies show that CBD can help treat an array of skin conditions such as eczema, psoriasis, rosacea, and acne.
"What is Intellectual Property?" - A Publication by the World Intellectual Property Organization -
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |